Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia

被引:0
作者
HJ Broxterman
J Lankelma
HM Pinedo
CA Eekman
DCR Währer
GJ Ossenkoppele
GJ Schuurhuis
机构
[1] Academisch Ziekenhuis Vrije Universiteit,Department of Medical Oncology
[2] Academisch Ziekenhuis Vrije Universiteit,Department of Hematology
来源
Leukemia | 1997年 / 11卷
关键词
P-glycoprotein; multidrug resistance; leukemia; PSC833; rhodamine 123;
D O I
暂无
中图分类号
学科分类号
摘要
This paper summarizes experimental data and theoretical considerations, that are important for the measurement of P-glycoprotein (Pgp) function in acute myeloid leukemia (AML). The data are presented in subdivisions based on the techniques used, which will facilitate finding specific information. Based on our extensive experience with Pgp analysis, which includes radioactive assays, flow cytometry and fluorescence microscopy, we recommend a flow cytometry-based assay, that measures the effect of 2 μ M PSC 833 on rhodamine 123 (R123) accumulation as the most practical and sensitive functional Pgp test. In combination with the flow cytometric measurement of Pgp using an antibody against an extracellular epitope (eg MRK16), this offers a sensitive and reproducible method for Pgp detection in AML, which is also rapid and practical. Furthermore, an R123 accumulation assay is specific for Pgp, because R123 is transported much less efficiently by the multidrug resistance protein (MRP) than by Pgp. Another probe of similar sensitivity and specificity is 3,3′-diethyloxacarbocyanine iodide. Alternatively, especially for the analysis of small numbers of cells (for example sorted subpopulations of leukemic cells), convenient and sensitive procedures are being developed by using DNA-binding Pgp substrates which remain fixed in the nuclei of the cells upon formaldehyde exposure for quantitative fluorescence laser scanning microscopy with image analysis. Less experimental data have been published to establish the optimal conditions for dual parameter flow cytometry (Pgp function, in eg Pgp+ or CD34+ cells). However, laboratories with flow cytometry experience will be able to implement this useful option to analyze subpopulations of cells.
引用
收藏
页码:1110 / 1118
页数:8
相关论文
共 50 条
  • [21] P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia
    Casale, F
    D'Angelo, V
    Addeo, R
    Caraglia, M
    Crisci, S
    Rondelli, R
    Di Tullio, MT
    Indolfi, P
    ONCOLOGY REPORTS, 2004, 12 (06) : 1201 - 1207
  • [22] LOW-FREQUENCY OF ACTIVITY OF P-GLYCOPROTEIN (P-170) IN ACUTE LYMPHOBLASTIC-LEUKEMIA COMPARED TO ACUTE MYELOID-LEUKEMIA
    LUDESCHER, C
    EISTERER, W
    HILBE, W
    GOTWALD, M
    HOFMANN, J
    ZABERNIGG, A
    CIANFRIGLIA, M
    THALER, J
    LEUKEMIA, 1995, 9 (02) : 350 - 356
  • [23] Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia
    Reis, Flaviana R. De S.
    Vasconcelos, Flavia Da C.
    Pereira, Debora L.
    Moellman-Coelho, Arthur
    Silva, Karina L.
    Maia, Raquel C.
    ONCOLOGY REPORTS, 2011, 26 (02) : 471 - 478
  • [24] Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients
    Nuessler, V
    Gullis, E
    PelkaFleischer, R
    delValle, F
    Diem, H
    Beyerlein, S
    Zwierzina, H
    Wilmanns, W
    ANNALS OF HEMATOLOGY, 1997, 75 (1-2) : 17 - 26
  • [25] Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients
    V. Nuessler
    E. Gullis
    R. Pelka-Fleischer
    F. del Valle
    H. Diem
    S. Beyerlein
    H. Zwierzina
    W. Wilmanns
    Annals of Hematology, 1997, 75 : 17 - 26
  • [26] Inhibition of P-glycoprotein function and expression by kaempferol and quercetin
    Limtrakul, P
    Khantamat, O
    Pintha, K
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (01) : 86 - 95
  • [27] P-glycoprotein expression in patients with acute leukemia - Clinical relevance
    Nussler, V
    PelkaFleischer, R
    Zwierzina, H
    Nerl, C
    Beckert, B
    Gieseler, F
    Diem, H
    Ledderose, G
    Gullis, E
    Sauer, H
    Wilmanns, W
    LEUKEMIA, 1996, 10 : S23 - S31
  • [28] P-glycoprotein and multidrug resistance-associated protein-1 expression in acute myeloid leukemia: Biological and prognosis implications
    da Silveira Junior, Lenilton Silva
    Soares, Victor de Lima
    Jardim da Silva, Alessandra Suelen
    Gil, Erica Aires
    Pereira de Araujo, Maria das Gracas
    Merces Goncalves, Ciro Alexandre
    Paiva, Aldair de Souza
    Moura de Oliveira, Taissa Maria
    de Medeiros Oliveira, Gustavo Henrique
    Cavacanti e Silva, Dany Geraldo Kramer
    de Araujo Moura Lemos, Telma Maria
    Moretti Rebecchi, Ivanise Marina
    de Farias Sales, Valeria Soraya
    Luchessi, Andre Ducati
    Cavalcanti Junior, Geraldo Barroso
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (05) : 594 - 603
  • [29] Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
    HJ Broxterman
    P Sonneveld
    R Pieters
    J Lankelma
    CA Eekman
    AH Loonen
    M Schoester
    GJ Ossenkoppele
    B Löwenberg
    HM Pinedo
    GJ Schuurhuis
    Leukemia, 1999, 13 : 258 - 265
  • [30] Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia
    Broxterman, HJ
    Sonneveld, P
    Pieters, R
    Lankelma, J
    Eekman, CA
    Loonen, AH
    Schoester, M
    Ossenkoppele, GJ
    Löwenberg, B
    Pinedo, HM
    Schuurhuis, GJ
    LEUKEMIA, 1999, 13 (02) : 258 - 265